HomeMarkets Markets “Strong” Phase 1/2 trial results for Moderna’s flu-COVID-19 combo jab By news October 6, 2023 0 107 FacebookTwitterPinterestWhatsApp Moderna, one pharmaceutical company inextricably linked to the pandemic vaccination response, has announced it will take its new seasonal influenza …This post was originally published on this site Share FacebookTwitterPinterestWhatsApp Subscribe Login Notify of new follow-up comments new replies to my comments Please login to comment 0 Comments Inline Feedbacks View all comments Stay Connected157,939FansLike396,312FollowersFollow2,240SubscribersSubscribe Latest Articles Charts The PhilStockWorld LIVE Weekly Webinar – 12-6-2023 Biotech Why the 23andMe Data Breach Is Such a Disaster Markets Why Israel’s intelligence chiefs failed to listen to October 7 warnings – and the lessons to be learned Markets Netanyahu Should Quit. The U.S. Can Help With That. Markets How deglobalization could ripple across the economy Load more